Chaobin He

1.3k total citations
62 papers, 984 citations indexed

About

Chaobin He is a scholar working on Oncology, Surgery and Biotechnology. According to data from OpenAlex, Chaobin He has authored 62 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 19 papers in Surgery and 18 papers in Biotechnology. Recurrent topics in Chaobin He's work include Pancreatic and Hepatic Oncology Research (27 papers), Microbial Inactivation Methods (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers). Chaobin He is often cited by papers focused on Pancreatic and Hepatic Oncology Research (27 papers), Microbial Inactivation Methods (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers). Chaobin He collaborates with scholars based in China, Singapore and United States. Chaobin He's co-authors include Xiaojun Lin, Shengping Li, Zhiyuan Cai, Xin Huang, Shuxin Sun, Yu Zhang, Yize Mao, Jun Wang, Yu Zhang and Xiang‐Ming Lao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Chaobin He

59 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaobin He China 20 532 282 219 208 160 62 984
Jantien A. Vogel Netherlands 14 743 1.4× 257 0.9× 450 2.1× 361 1.7× 230 1.4× 28 1.2k
Ayako Fujiwara Japan 15 375 0.7× 170 0.6× 60 0.3× 444 2.1× 117 0.7× 37 895
Yoshiyuki Kobayashi Japan 21 266 0.5× 200 0.7× 87 0.4× 222 1.1× 227 1.4× 54 1.3k
Tomotake Koizumi Japan 16 308 0.6× 373 1.3× 41 0.2× 144 0.7× 113 0.7× 53 877
Paola Bossi Italy 11 462 0.9× 244 0.9× 48 0.2× 159 0.8× 186 1.2× 30 1.0k
Laurentiu M. Pop United States 19 318 0.6× 90 0.3× 101 0.5× 170 0.8× 88 0.6× 41 931
Takao Ide Japan 15 321 0.6× 272 1.0× 31 0.1× 187 0.9× 263 1.6× 57 843
Alex Chehrazi‐Raffle United States 11 869 1.6× 138 0.5× 39 0.2× 331 1.6× 171 1.1× 64 1.3k
Michitaka Nakano Japan 14 527 1.0× 67 0.2× 45 0.2× 90 0.4× 118 0.7× 33 764

Countries citing papers authored by Chaobin He

Since Specialization
Citations

This map shows the geographic impact of Chaobin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaobin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaobin He more than expected).

Fields of papers citing papers by Chaobin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaobin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaobin He. The network helps show where Chaobin He may publish in the future.

Co-authorship network of co-authors of Chaobin He

This figure shows the co-authorship network connecting the top 25 collaborators of Chaobin He. A scholar is included among the top collaborators of Chaobin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaobin He. Chaobin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Haijie, Junhan Wu, Jianrong Chen, et al.. (2025). Machine learning for predicting the prognosis of patients with thymoma and thymic carcinoma. Journal of Thoracic Disease. 17(2). 824–835.
2.
Jiang, Lingmin, et al.. (2025). The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis. Journal of Inflammation Research. Volume 18. 621–635. 4 indexed citations
3.
Zhao, Chongyu, et al.. (2023). Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma. Cancer Cell International. 23(1). 148–148. 1 indexed citations
5.
Sun, Shuxin, Yang Liu, Chaobin He, et al.. (2021). Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Cancer Letters. 502. 9–24. 36 indexed citations
6.
He, Chaobin, Shuxin Sun, Yu Zhang, & Shengping Li. (2021). Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer. Journal of Inflammation Research. Volume 14. 4795–4807. 25 indexed citations
7.
Cai, Zhiyuan, Chaobin He, Chongyu Zhao, & Xiaojun Lin. (2021). Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 11. 611118–611118. 26 indexed citations
8.
He, Chaobin, Xin Huang, Yu Zhang, Xiaojun Lin, & Shengping Li. (2021). The impact of different metastatic patterns on survival in patients with pancreatic cancer. Pancreatology. 21(3). 556–563. 19 indexed citations
9.
He, Chaobin, Chongyu Zhao, Yu Zhang, Cheng Chen, & Xiaojun Lin. (2021). An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. Journal of Inflammation Research. Volume 14. 1859–1872. 5 indexed citations
10.
He, Chaobin, Shuxin Sun, Yu Zhang, Xiaojun Lin, & Shengping Li. (2020). A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection. Frontiers in Oncology. 10. 1564–1564. 4 indexed citations
11.
Lu, Lianghe, et al.. (2020). A Novel Prognostic Nomogram for Patients With Recurrence of Intrahepatic Cholangiocarcinoma After Initial Surgery. Frontiers in Oncology. 10. 434–434. 11 indexed citations
12.
He, Chaobin, Xin Huang, Yu Zhang, et al.. (2020). Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 10. 6–6. 22 indexed citations
13.
Huang, Xin, Chaobin He, Guo‐He Lin, et al.. (2020). Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications. 524(4). 1064–1071. 19 indexed citations
14.
Sun, Shuxin, Chaobin He, Jun Wang, et al.. (2020). The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy. BMC Cancer. 20(1). 981–981. 10 indexed citations
16.
He, Chaobin, Yu Zhang, Zhiyuan Cai, & Xiaojun Lin. (2019). Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. BMC Cancer. 19(1). 178–178. 31 indexed citations
18.
He, Chaobin, Yu Zhang, Zhiyuan Cai, Xiaojun Lin, & Shengping Li. (2018). Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis. Journal of Cancer. 9(17). 3156–3167. 41 indexed citations
19.
He, Chaobin & Shaozhi Li. (2018). Nomogram to predict cancer-specific survival in patients with pancreatic acinar cell carcinoma: A competing risk analysis. Annals of Oncology. 29. ix60–ix60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026